Your browser doesn't support javascript.
loading
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus.
Glaysher, Michael Alan; Mohanaruban, Aruchuna; Prechtl, Christina Gabriele; Goldstone, Anthony P; Miras, Alexander Dimitri; Lord, Joanne; Chhina, Navpreet; Falaschetti, Emanuela; Johnson, Nicholas Andrew; Al-Najim, Werd; Smith, Claire; Li, Jia V; Patel, Mayank; Ahmed, Ahmed R; Moore, Michael; Poulter, Neil; Bloom, Stephen; Darzi, Ara; Le Roux, Carel; Byrne, James P; Teare, Julian P.
Afiliação
  • Glaysher MA; Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, Hampshire, UK.
  • Mohanaruban A; Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK.
  • Prechtl CG; Department of Public Health, Imperial College London, Imperial Clinical Trials Unit, London, UK.
  • Goldstone AP; PsychoNeuroEndocrinology Research Group, Neuropsychopharmacology Unit, Centre for Psychiatry and Computational, Cognitive and Clinical Neuroimaging Laboratory, Division of Brain Sciences, Imperial College London, London, UK.
  • Miras AD; Division of Diabetes, Endocrinology and Metabolic Medicine, Hammersmith Hospital, London, UK.
  • Lord J; Southampton HTA Centre, University of Southampton, University of Southampton Science Park, Southampton, UK.
  • Chhina N; Computational Cognitive and Clinical Neuroimaging Group, Hammersmith Hospital, Imperial College London, London, UK.
  • Falaschetti E; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Johnson NA; School of Public Health, Imperial College London, London, UK.
  • Al-Najim W; Department of Investigative Medicine, Imperial College London, London, UK.
  • Smith C; Diabetes Complications Research Centre, Conway Institute, Dublin, Ireland.
  • Li JV; School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland.
  • Patel M; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Ahmed AR; Division of Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
  • Moore M; Department of Diabetes and Endocrinology, Southampton General Hospital, Southampton, UK.
  • Poulter N; Imperial College Healthcare NHS Trust, St Mary's Hospital, London, UK.
  • Bloom S; Primary Care Medical Group, University of Southampton Medical School, Southampton, UK.
  • Darzi A; Imperial Clinical Trials Unit, Imperial College London, London, UK.
  • Le Roux C; North West London Pathology, Head of Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Hospital, London, UK.
  • Byrne JP; Division of Surgery, Imperial College London, London, UK.
  • Teare JP; Head of Pathology, University College Dublin, Dublin, Ireland.
BMJ Open ; 7(11): e018598, 2017 Nov 15.
Article em En | MEDLINE | ID: mdl-29146657
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Derivação Gástrica / Diabetes Mellitus Tipo 2 / Duodeno / Jejuno Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Derivação Gástrica / Diabetes Mellitus Tipo 2 / Duodeno / Jejuno Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article